OREGA Biotech specializes in the discovery and the development of first-in-class monoclonal antibodies for cancer immunotherapy. With a specific focus on tumor microenvironment, OREGA's Target Discovery Program aims at discovering and validating nove...Show all
Company (Alive / Active)
Phone:
Ecully,
France
Per Week | Per Month | Per 6 Months | Per Year | |
---|---|---|---|---|
Rank | Login to see details | |||
Page Views Per Million | Login to see details | |||
Page Views Per User | Login to see details | |||
Reach Per Million | Login to see details |
Title | Application Date | Patent Date | Status (Patent / Application) |
---|---|---|---|
Antagonists of il-17 isoforms and their uses | Nov 20, 2017 | Jul 16, 2019 | Patent |
Antagonists of il-17 isoforms and their uses | Jun 11, 2013 | Dec 05, 2017 | Patent |
Il-17 antagonist antibodies | Jun 25, 2013 | Jun 13, 2017 | Patent |
File management system and file management method | Aug 20, 2012 | Apr 26, 2016 | Patent |
Combinations therapies for the treatment of cancer | May 09, 2017 | Application |